| Date Filed | Type | Description |
| 01/18/2023 |
4
| Taub Rebecca (Pres., R&D, and CMO) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 20,001 shares
@ $0 |
|
| 08/01/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2019 |
SC 13D/A
| Taub Rebecca reports a 8.2% stake in Madrigal Pharmaceuticals, Inc. |
| 07/11/2019 |
4
| Taub Rebecca (President of R&D) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 8,000 options to buy
@ $101.3, valued at
$810.4k
|
|
| 03/11/2019 |
4
| Taub Rebecca (Chief Medical Officer, EVP R&D) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 38,000 options to buy
@ $127.96, valued at
$4.9M
|
|
| 06/12/2018 |
4
| Taub Rebecca (Chief Medical Officer, EVP R&D) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Sold 73,526 shares
@ $287.46, valued at
$21.1M
|
|
| 03/05/2018 |
4
| Taub Rebecca (Chief Medical Officer, EVP R&D) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 38,000 options to buy
@ $124.45, valued at
$4.7M
|
|
| 03/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/23/2016 |
4/A
| Taub Rebecca (Chief Medical Officer, EVP R&D) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Granted 30,626 shares
@ $0
Granted 153,128 options to buy
@ $9.45, valued at
$1.4M
|
|
| 08/01/2016 |
SC 13D
| Taub Rebecca reports a 10.4% stake in Madrigal Pharmaceuticals, Inc. |
| 07/26/2016 |
4
| Taub Rebecca (Chief Medical Officer, EVP R&D) has filed a Form 4 on SYNTA PHARMACEUTICALS CORP|
Txns:
| Granted 729,066 shares
@ $0
Granted 404,132 shares
@ $0
Granted 28,740 shares
@ $0
Granted 143,557 options to buy
@ $9.45, valued at
$1.4M
|
|
| 07/26/2016 |
3
| Taub Rebecca (Chief Medical Officer, EVP R&D) has filed a Form 3 on SYNTA PHARMACEUTICALS CORP |
| 12/19/2008 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |